Cell Therapeutics, Inc. (NASDAQ: CTIC)

501 Elliott Ave. West, Ste. 400
Seattle, WA 98119 (Map)
Phone: 206-282-7100
Fax: 206-284-6206
Toll Free: 800-215-2355
http://www.cticseattle.com

Hoover's coverage by Anne Law

Overview

Cell Therapeutics (CTI) is a toxic avenger. The firm creates more effective and less toxic treatments for various forms of cancer. CTI is developing a number of cancer-fighting compounds, including pixantrone, a treatment for non-Hodgkin's lymphoma and other tumorous cancers, and Opaxio (paclitaxel poliglumex) for non-small cell lung and ovarian cancers. The company's Systems Medicine subsidiary is working on a potential sarcoma-fighter called brostallicin. CTI no longer markets any commercial products and instead focuses on research and development projects.

Sample Overview

Key Numbers from Hoover's UK

Key financials for Cell Therapeutics, Inc. (NASDAQ: CTIC)

Company Type Public (NASDAQ: CTIC)
Fiscal Year-End December
2010 Sales (mil.) £0.2
1-Year Sales Growth 298.8%
2010 Net Income (mil.) (£53.4)
2010 Employees 88
1-Year Employee Growth (15.4%)
Get more Key Numbers
TIP: Understand how a company performs against its industry by reviewing Comparison Data. Column-to-column comparisons to the industry and the market are available with a Hoover's subscription.
TIP: Subscribers have access to detailed financial data (income statement, balance sheet, cash flow) for more than 500,000 public and private companies in the UK.

Key People from Hoover's UK

Key people and executives for Cell Therapeutics, Inc. (NASDAQ: CTIC)

Chairman Phillip M. (Phil) Nudelman
(Subscribers see complete biographies -- view sample)
CEO and Director James A. Bianco
EVP Finance and Administration Louis A. Bianco
TIP: Use Build Executive List to target decision makers by industry, geography, sales, net income, and number of employees.

Top Competitors from Hoover's UK

Top competitors of Cell Therapeutics, Inc. (NASDAQ: CTIC)

There are 18 competitors for Cell Therapeutics; see more.
TIP: Analyze the Competitive Landscape to view a head-to-head comparison of a firm's profitability, operations, growth, and valuation versus that of its top three competitors.

Industry Information from Hoover's UK

First Research Industry Profiles Extensive Industry Intelligence

Hoover's Industries

More Industry Information
TIP: Hoover's proprietary industry structure allows you to tell at-a-glance how diversified a company's operations are, and which line of business can be considered a company's primary industry.

Rankings from Hoover's UK

See how Cell Therapeutics, Inc. (NASDAQ: CTIC) ranks in standard industry listings such as Fortune 500, S&P 500, and Dow Jones

TIP: Hoover's subscribers have access to FT 500 and other rankings that make targeted list building easy.

Subscribers Get More!

Search Hoover's UK

View Hoover's UK Free Content

Buy A Report on Cell Therapeutics:

Sample UK Subscriber Content


Bizmology

No Christmas wrapping on toy safety reforms

by Linnea Kirgan, Jan. 2nd, 2008
Read more at Bizmology.com.


Companies That Exceed Expectations

Who's going above and beyond the status quo? Learn more about these groundbreaking companies!

Current Edition: Click Here



Small Business Expert

Presented by Comcast Business Class

Read More from the Current Edition: Performance Reviews

Click Here


Copyright © 2012, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy